Location: Oslo, Norway
CIK: 0001475373 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 7, 2026
Total Value: $423M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 827,901 | $50.21M | 11.9% | $49.36 | +16.3% | COM | 110122108 |
| MRK | MERCK & CO INC | 260,340 | $31.32M | 7.4% | $80.39 | +42.2% | COM | 58933Y105 |
| PFE | PFIZER INC | 1,091,385 | $30.65M | 7.2% | $25.58 | +2.3% | COM | 717081103 |
| MDT | MEDTRONIC PLC | 280,682 | $24.32M | 5.7% | $84.37 | +17.9% | SHS | G5960L103 |
| INCY | INCYTE CORP | 200,510 | $18.87M | 4.5% | $71.18 | +44.9% | COM | 45337C102 |
| AMGN | AMGEN INC | 47,155 | $16.59M | 3.9% | $285.08 | +22.7% | COM | 031162100 |
| BIIB | BIOGEN INC | 90,096 | $16.52M | 3.9% | $165.19 | +10.9% | COM | 09062X103 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 155,835 | $14.09M | 3.3% | $104.78 | -12.5% | COM | 98956P102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 239,918 | $13.55M | 3.2% | $69.95 | -16.1% | COM | 09061G101 |
| BDX | BECTON DICKINSON & CO | 82,615 | $12.99M | 3.1% | $211.58 | -20.7% | COM | 075887109 |
| ELV | ELEVANCE HEALTH INC FORMERLY | 43,962 | $12.87M | 3.0% | $351.21 | +0.1% | COM | 036752103 |
| IONS | IONIS PHARMACEUTICALS INC | 169,468 | $12.73M | 3.0% | $46.09 | +77.5% | COM | 462222100 |
| CAH | CARDINAL HEALTH INC | 54,897 | $11.6M | 2.7% | $64.47 | +234.0% | COM | 14149Y108 |
| UNH | UNITEDHEALTH GROUP INC | 36,435 | $9.859M | 2.3% | $308.69 | 0.0% | COM | 91324P102 |
| CVS | CVS HEALTH CORP | 135,337 | $9.72M | 2.3% | $65.57 | +18.9% | COM | 126650100 |
| BRKR | BRUKER CORP | 254,010 | $9.175M | 2.2% | $51.49 | -11.8% | COM | 116794108 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 126,418 | $8.998M | 2.1% | $76.82 | +7.1% | COMMON STOCK | 36266G107 |
| ABT | ABBOTT LABS | 87,532 | $8.987M | 2.1% | $115.41 | 0.0% | COM | 002824100 |
| GILD | GILEAD SCIENCES INC | 53,247 | $7.421M | 1.8% | $75.45 | +83.4% | COM | 375558103 |
| LNTH | LANTHEUS HLDGS INC | 93,344 | $7.08M | 1.7% | $74.91 | -8.6% | COM | 516544103 |
| IQV | IQVIA HLDGS INC | 40,230 | $6.861M | 1.6% | $210.16 | 0.0% | COM | 46266C105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 286,007 | $6.681M | 1.6% | $14.63 | +41.9% | COM | 87164F105 |
| BIO | BIO RAD LABS INC | 23,750 | $6.62M | 1.6% | $294.39 | +1.5% | CL A | 090572207 |
| QGEN | QIAGEN NV | 162,371 | $6.501M | 1.5% | $50.32 | 0.0% | ORD SHARES | N72482156 |
| AVTR | AVANTOR INC | 695,403 | $5.452M | 1.3% | $13.13 | -16.2% | COM | 05352A100 |
| CNC | CENTENE CORP DEL | 162,405 | $5.317M | 1.3% | $53.34 | -18.7% | COM | 15135B101 |
| TNDM | TANDEM DIABETES CARE INC | 267,091 | $5.12M | 1.2% | $24.77 | -14.9% | COM NEW | 875372203 |
| PTCT | PTC THERAPEUTICS INC | 75,000 | $5.11M | 1.2% | $51.21 | +43.9% | COM | 69366J200 |
| LH | LABCORP HOLDINGS INC | 19,019 | $5.074M | 1.2% | $248.69 | +9.0% | COM SHS | 504922105 |
| ASND | ASCENDIS PHARMA A/S | 21,305 | $4.873M | 1.2% | $182.86 | — | SPONSORED ADR | 04351P101 |
| EW | EDWARDS LIFESCIENCES CORP | 60,402 | $4.837M | 1.1% | $78.07 | +5.0% | COM | 28176E108 |
| DXCM | DEXCOM INC | 56,122 | $3.524M | 0.8% | $78.65 | -9.8% | COM | 252131107 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 94,195 | $3.421M | 0.8% | $44.52 | +10.5% | COM | 22663K107 |
| KURA | KURA ONCOLOGY INC | 411,810 | $3.348M | 0.8% | $7.26 | +18.7% | COM | 50127T109 |
| HUM | HUMANA INC | 19,202 | $3.329M | 0.8% | $223.53 | 0.0% | COM | 444859102 |
| BBIO | BRIDGEBIO PHARMA INC | 44,263 | $3.287M | 0.8% | $74.48 | 0.0% | COM | 10806X102 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 900,000 | $3.159M | 0.7% | $2.68 | 0.0% | COM | 462260100 |
| DNLI | DENALI THERAPEUTICS INC | 162,710 | $3.124M | 0.7% | $19.63 | 0.0% | COM | 24823R105 |
| ARDX | ARDELYX INC | 516,131 | $3.092M | 0.7% | $7.08 | 0.0% | COM | 039697107 |
| COGT | COGENT BIOSCIENCES INC | 80,000 | $3.079M | 0.7% | $37.37 | 0.0% | COM | 19240Q201 |
| OGN | ORGANON & CO | 375,974 | $2.252M | 0.5% | $9.46 | -13.1% | COMMON STOCK | 68622V106 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 30,000 | $1.881M | 0.4% | $65.73 | 0.0% | COM | 04280A100 |